TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Clinical Trials: Breast Cancer Prevention Trial requires Fewer Participants, NCI Says September 6, 1996
TCL Archive NCI Plans Program To Help Academics With Initial Stages of Drug Discovery. November 30, 2007
TCL Archive NCI Plans To Recomplete CCOP; Future Direction To Be Discuss At DCPC Board, NCAB Meetings January 17, 1986